HIGHLIGHTS
- who: Ted Wun and colleagues from the Division of Hematology Oncology, University of California Davis School of Medicine, Sacramento, California, United States of America, Clinical and Translational have published the research work: Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia, in the Journal: PLOS ONE | www.plosone.org of December/10,/2013
- what: The aim was to evaluate the safety of two intravenous (IV) doses of GMI 1070 in adults with sickle cell disease (SCD). This study provides mechanismbased evidence of effect of GMI 1070 in this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.